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prior to Amplatzer device implantation. 3D was performed with transthoracic rotational 
acquisition at 3’ intervals (TomTec Echoscan 3.0). Diameters of defect, predicted mean 
diameter and drea were measured by TEE and 3D. Results were compared to stretched 
balloon diameter and final Amplatzer waist diameter. All patients underwent successful 
implantation procedure wthout residual leaks after 6 months. 
Results. Quality of 3D was good in 11 pts and satisfactory in 7. Mean stretched/ 
Amplatzer diameter was 20r5/22+5mm and stretched/Amplatzer waist area 3.2t1.61 
3.9k2.0 cm2. Maximal diameters were severely underestimated by TEE and not by 3D: 
14*4 vs 23*5 mm (p<O.OOl), with calculated areas of 1.2i0.6 vs 2.9+1.5cm2 resp. 
(p<O.OOl). 30 had good correlation and close agreement to stretch diameter (r=0,87) 
with small underestimation (3mm) of true size of implanted device. TEE underestimated 
defect size markedly by >6mm (r=0,59). 
1168-155 Systemic Dissemination of Nickel in Patients With Atrial Conclusions. Transthoracic 3D, as opposed to TEE, allows accurate transthoracic mea- 
Septal Defects Following the Implantation of the surements of ASD diameter and reliable prediction of Amplatzer size in young patients. 
Amplatzer Septal Occluder P-dimensional measurements significantly underestimate defect dimensions. 
Thomas Neumann, Draga Petkovic, Maria Burian. Michael W. Weber, Matthias Rau, 
Roland R. Brandt, Thorsten Dill, Christian Hamm, Kerckhoff Heart Center, Bad Nauheim, 
Germany, Johann-Wolfgang-Goethe-University, Frankfurt, Germany 
Background: Transcatheter techniques to close atrial septal defects with the 
AmplatzerTM Septal occluder or other devices have been used with increasing frequency 
during the last few years. Most of these devices contain a Nickel-titanium alloy (Nitinol). 
Several published in vitro and in viva studies on a dog model could demonstrate a dis- 
semination of Nickel into ambient tissue. However, there is no data available on the 
release and the time course of release of nickel due to in patients degradation of Nitinol 
implants used for closure of atrial septal closure devices.The purpose of this prospective 
in situ study was to investigate the systemic dissemination of nickel following transcathe- 
ter closure of atrial septal defects of the secundum type. Methods: Blood samples were 
obtained from 10 patients before, 1 week, 2 weeks, 4 weeks, 8 weeks and 24 weeks after 
the procedure. Additionally, blood samples were drawn from 5 healthy patients. Serum 
concentrations of nickel were determined using inductwely coupled plasma-mess spec- 
trometry (ICP-MS, detection limit 0,3 F g/l). Transoesophageal echocardiography and 
magnetic resonance imaging were performed in all patients before, 4 weeks and 24 
weeks after the implantation. Results: BaselIne concentrations of nickel in 9/10 patients 
were within the normal range (c2@ g/l) and comparable between both groups: 1,62* 
1 ,Oi k g/l in patients vs 1,66* 1,041” g/l in the control group. Serum nickel IeVelS raised 
continuously, showmg a peak value up to 15,@ @ wthin 4 weeks after the procedure. 
Nickel levels returned to normal serum concentrations after 24 weeks. During the follow- 
up two patients with a transitional residual shunt and higher nickel serum levels com- 
pared to the other patients (p=O,O2) were obsewed. Conclusion: Systematic dissemina- 
tion of Nickel after pecutaneous closure of atrial septal defects of the secundum type can 
be meassured in the blood serum samples. This observation may reflect the endotheliaz- 
ation process of the graft. 
1168-158 Long-Term Follow-Up (15-Year) Results of Balloon 
Coarctation Angioplasty in the Adolescent and Adult 
Patient 
1168-156 Is Echocardiographic Guidance Necessary for Device 
Closure of Patent Foramen Ovale? 
PhillIp Moore, Monica S. Divakaruni, University of California at San Francisco, San 
Francisco, CA 
Background: Transcatheter device closure of patent foramen ovale (PFO) has routinely 
been performed using transesophageal echocardiographic (TEE) guidance in addition to 
fluoroscopy. Echocardiographic guidance adds significant cost and potential risks to the 
procedure. Multiple studies allude to the fact that device closure can be performed with- 
out TEE guidance; however, none have compare outcomes of these two approaches. 
This repolt compares our experience of device PFO closure with and without TEE guid- 
ance. Methods: Data were collected retrospectively from hospital records of all patients 
who underwent transcatheter PFO closure between 9196 and 6102 at UCSF. Results: Out 
of 62 patients who had attempted PFO device closure, 27 (median age 46 years (18 to 
61) had TEE assisted fluoroscopic guidance, while the remaining 55 patients (median 
age 47 years (12 to 61) had fluoroscopic guidance alone. All attempts were successful. 
Of those implanted with TEE guidance, the mean procedure time was 116 + 32 minutes 
with a mean fluoroscopy time of 33 + 15 minutes. Those without TEE guidance had a 
procedure time of 106 + 32 minutes and a fluoroscopy time of 26+ 20 minutes, not signif- 
icantly different. The rate of immediate post-procedure residual right to left shunt by right 
atrial angiogram was small or trivial in 9123 (39%) without TEE compared to 15/54 (26%) 
with TEE. The rate of right to left shunting at discharge defined by saline contrast with 
valsalva on transthoracic echocardiogram was 6127 (30%) in the TEE group and 17154 
(31%) in the non TEE group. Minor complications were seen in 3127 in the TEE group, 
none related to the TEE. One patient in the non TEE group had a minor complication 
necessitating transthoracic echocardiogram during the procedure. Conclusions: These 
data indicate that transcatheter device PFO closure may be safely and effectively per- 
formed with only fluoroscopic guidance with equivalent results to that with TEE assisted 
fluoroscoplc guidance. The elimination of echo support for this procedure may signifi- 
cantly reduce cost and complexity of the procedure. 
1168-157 Transthoracic 3-D Echocardiography Improves the 
Quantification of Atrial Septal Defect Size Before 
Amplatzer Closure 
Jaroslaw D. Kasprzak, Andrzej Sysa, Maria Krzeminska-Pakula, Michal Ciesielczyk, 
Pawel Dryzek. Jadwiga Mall, Josef Masura, Jaroslaw Drozdz, Medical University of 
Lodz, Poland, Lodz. Poland, Polish Mother’s Health Centre, Lodz, Poland, Lodz, Poland 
Aim of the study was to compare transthoracic three-dimensional echocardiography (3D) 
with transesophageal 2-dimensional echo (TEE) for the evaluation of secundum atrial 
septal defect (ASD) before intewentional closure with Amplatzer device 
Method. 16 children and young adults (3-20 years, 11*6) were studied with 3D and TEE 
. 
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Mohamed Eid K. Fawz& Mahmoud Awad, Hesham Hegazy. Bruce Dunn, Mohammed 
Shoukri, Zohair Al-Halees, King Faisal Specialist Hospital and Research Centre, Riyadh, 
Saudi Arabia 
The long-term results of balloon angioplasty (BA) of coarctation of the aorta (Con) in 
adolescent and adult patients (pts) have not been well characterized. 
Methods: Between July 1966 and July 2001, 51 consecutive pts (36 male) underwent 
BA for native CoA. Their ages ranged from 15-55 (mean 22 f 7) yrs. One to 15 years fol- 
low-up data using repeat cardiac catheterization at one year and clinical examination and 
magnetic resonance imaging (MRI) annually up to 15 years form the basis of this study. 
Paired t-test was used to compare data before and after BA and at follow-up. P < 0.05 
was consldered significant. 
Results: No early or late deaths occurred. Peak coarctation gradient (PCG) decreased 
from 65 * 23 (mean * SD) to 10.4 f 7.3 mmHg (P < 0.0001). Restenosis defined as gra- 
dient > POmmHg across CoA occurred in 4 pts (7.6%). 3 of whom underwent redilation 6 
months later, and one underwent surgery. There was further drop in PCG at follow-up 
catheterization 12 months later to 7.2 f 7.9 mmHg (P < 0 05). Aneurysm was noted in 4 
pts (6%); in 3 of them the aneurysm was very small. One pt underwent surgical repair for 
medium size aneurysm one year later. 49 pts were followed-up by MRI for l-15 (mean 
7.4 f 4) years. No new aneurysm or recoarctation was noted and no Increase of the size 
of the 3 small aneurysms on follow-up MRI up to 15 years. Blood pressure was normal 
without medication in 31 pts (63%). 
Conclusions: BA for native CoA is safe and effective procedure. Its long-term results 
are satisfactory and should be the first option for treatment of native CoA in adults. 
1168-159 Fate of Infants With Severe Coarctation of Aorta Treated 
Early With Balloon Angioplasty: A 19-Year Study 
Jose SuBrez de Lezo, Alfonso Medina, Manuel Pan, Miguel Romero, Jose Segura, Luis 
Burgos. Antonio Delgado, Djordje Pavlovic, Marcos Rodriguez. Juan MuAoz, Carmen 
Rus, Fsderico Segura, ReIna Sofia Hospital, Cdrdoba, Spain, Dr. Negrin Hospital, Las 
Palmas, Spain 
Background: Infants with coarctation of aolfa (Con) presenting wth heart failure may be 
palliated by balloon angioplasty. However, controversy still persists regarding the useful- 
ness of this procedure and there is no informatlon on the need for further treatments until 
reaching adulthood. Methods:This study analyses the long-term evolution of a series of 
54 infants with severe CoA treated by balloon angioplasty, 35 of them (65%) had CISSoci- 
ated malformations and 3 had previous surgery. The mean age at first treatment was I+1 
months; 34 of them were neonates. ReSults:The significant reduction of gradient always 
improved the clinical condition, leadlng to prevent the need for surgery at this early stage 
in 35 (65%). However, initial mortality was 16% (n=9). Following this palliation the long- 
term evolution (IO+6 years) of survivors and the need for a second, third of fourth proce- 
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dure is summarized in the flow-chart. No further mortality was observed. Balloon angio- 
plasty or stent implantatron, applied as a second, third or fourth percutaneous procedure, 
were definitive in 16 (35%); combined surgery as second or third stage was a definitive 
procedure for coarctation in 12 (27%); 27 patients (60%) remarn treated by percutaneous 
techniques at a mean follow-up time of 9*5 years. However, 17 of them remain with a 
single stags procedure in a shorter follow-up period (6*4 years). ConclusioruCombined 
percutaneous and surgical procedures are frequently needed for the management of 
severe CoA presenting at early age. 
1168-160 Flow Characteristics Predict In-Stent Restenosis in 
Congenital Heart Disease 
Joseph A. Paolillo, Jr., Jacqueline Kreutzer, Bernard J. Clark, Jonathan J. Rome, The 
Cardiac Center at the Children’s Hospital of Philadelphia, Phrladelphia, PA 
Background: lntimal proliferation is a common complication of endovascular stent 
placement in many settings, though its importance in stents used for congenital heart dis- 
ease has been controversial. We reviewed our experience to determkw the frequency 
and potential predictors of significant in-stent restenosis (ISR). 
Methods: All patients who had undergone endovascular stent placement were identified. 
Angiograms were evaluated at stent placement and the most recent catheterization prior 
to reintervention. Measurements were obtained from digital archive or 35mm film. ISR 
was defined as > 25% reduction in vessel diameter. Descriptive data were described as 
mean * standard deviation or medran with range as appropriate. Groups were compared 
using students t-test for normally distributed and Mann-Whitney U for nonparametric 
data. Two-tailed significance was set at p < 0.05. 
Results: Between 8194, and lO/Ol, 123 stems were placed in 96 patrents; 51 (41%) 
underwent follow-up catheterization. Thirty-six PalmazB (PS) and 15 IntraStent& (IS) 
were placed in 41 pulmonary arteries, 4 aortas, 3 veins, and 3 conduits/baffles. Median 
age at deployment was 1.7 years (range 0.4-28.6). At 14.2 f 11.4 months follow-up, 
neointimal proliferation ranging from 0.5 to 3.6mm was present rn 27151 stents (53%). 
Proliferation was focal in 8. diffuse rn 19, and caused significant ISR in 15/51 (29%). ISR 
was not associated with the technical aspects of deployment (overdilation, incomplete 
stent expansion, distal vessel stenoses), or stent type. However, flow characteristics and 
stent srze predrcted restenosrs. ISR occurred in 8% of vessels with non-pulsatile flow 
(veins and pulmonary arteries in a cavopufmonary circulation), compared with 37% in 
which flow was pulsatrle (p < 0.04). ISR did not develop in any vessel > 9mm in diameter. 
Complications included thrombosis wrthin one PS (innominate vein), fracture in one IS 
(coarctation), and restenosis of a previously dilated jailed side branch. 
Conclusion: ISR is important in stents used for congenital heart disease, particularly at 
smaller diameters. Blood flow dynamics play an essential role fn the development of 
neointimaf proliferation. 
1166-161 Pulse Pressure Propagation Changes in the Aorta With 
a Stent: An In Vitro Study Simulating an Adequate 
Result of Coarctation Treatment With a Stent in Place 
Xiaokui Li. lkuo Hashimoto, Brent J. Barber, Aarti Heimadi Grant H. Burch, David J. 
Sahn, Ron Sakaguchr. Oregon Health 8 Science University Portland, OR 
Background: Interposition of a noncompliant stent within the aorta may result in a pres- 
sure gradient across the stent at rest and during exercise. This rn vitro study was aimed 
to characterize the pressure changes within the stem and measure pulse wave propaga- 
tion though it. Methods: A pulsatile pump. generating 6 stroke volumes (15 - 40 mlibeat) 
with heart rate 50 and 85 bpm, was connected to 3 fresh descending thoracic pig aortas 
(22 cm long). The proximal (prox) segment was denatured by heating to model abnormal 
prox aortic stiffness (prox: 6 = 4.5; distal: 6 = 2.74); 4 cm long endovascular stents (Pal- 
maz 4014) were then expanded to the diameter of the aorta (e 14-18 mm) yrelding a 
stented segment with stiffness index of 6 = 5.9. Results: Pressure gradient across the 
“repaired” coarctation before stenting ranged from 3-17 mmHg peak to peak and 5.18 
mmHg with “exercise”. After stent placement, gradients were 2-22 mmHg at rest and 4. 
28 mmHg with “exercise”. Peak systolic pressures wrthin the stem were higher than the 
prox pressures, mean: 12.89 * 2.84%, p = 0.04 at rest and with ‘exercise” 17 * 3.14%, p 
< 0.0001 Pulse wave propagation correlated well with flow resistance and the pressure 
increase (r = 0.78) in the stented segment. Conclusions: Our study showed that place- 
ment of a noncompkant stent with the increased stiffness of the segment and the resuft- 
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ing increased rate of pulse wave propagation produces a pressure increase within the 
stem and increases the total maximal gradient across the aorta. 
1168-162 Follow-Up Results of Cutting Balloon Angioplasty for 
Pulmonary Artery Stenosis in Children 
Lisa Beraersen Audrey C. Marshall, Peter Lang, Stanton 8. Perry, James E. Lock, 
Children’s Hospital Boston, Boston, MA 
Background: Cutting Balloon angioplasty (CBA) appears to acutely enlarge branch pul- 
monary arteries (PA) previously resistant to transcatheter therapy, although vascular 
“trauma’ and the need for rescue stenting seems to be more prevalent. We therefore 
analyzed follow-up catheterization (flu cath) data following CBA to look for early resteno- 
sis or progressive aneurysms. 
Methods: A data base search (IRB approved) identified all patients who underwent CBA 
for PA stenosis from 6101 to E/02. The analysis was limrted to individuals with f/u cath 
data and adequate PA angiography. 
Results: Ten patients ages 0.4-10 years, median 2 years, who received CBA for one or 
more PAS resistant to conventional high pressure (> 8 ATM) balloon therapy were also 
catheterized 6 +/- 2 months after the initial CBA. At the imtial CBA procedure in these 10 
patients, 30 vessels with an initial minimum lumen diameter of 1.5 +/- 0.9 mm were 
enlarged to 3 1 +/- 1.2 mm (p> 0.001); 93% of the procedures were successful at enlarg- 
ing the vessel z 50% Fourteen of the 30 vessels had anglographic evidence of vascular 
damage and 7 of these 14 vessels required additional stent placement. 
At flu cath, 8 of 30 PAS had evidence of restenosis as defkwd by a > 50% loss in the ini- 
tial enlargement of the PA diameter. Four of these PAS required a stent at the initial pro- 
cedure; 1 of 4 stents was occluded. Of the 4 remaining PAS, 3 had angiographic 
evidence of vascular damage following CBA; 1 PA, which did not meet criteria for suc- 
cessful anoioplastv at the initial orocedure. lost the minimal aains achreved. All the rest- _. ~ 
anotic PAS, except for the occluded stent. underwent further angioplasty to enlarge the 
PA lumen from 2.3 +/- 1 .O mm to 3.7 +/- 0.4 mm (vessel diameter after CBA 3.5 +I- 0.9 
mm). The remaining 22 PAS maintarned a lumen diameter of 2.8 +/- 1.3 mm compared to 
2.9 +I- 1.3 mm after CBA. No progressive aneurysms occurred in the follow up interval. 
Conclusions: Restenosis occurred in half of the PAS with a stent or angiographic evi- 
dence of vascular damage following CBA. The remaining 74% of CBA treated PAS main- 
tained initial gains in diameter without developing aneurysms at f/u cath. These data 
suggest that “conservatrve” CBA techniques may result in less PA restenosis. 
POSTER SESSION 
1192 Adult Congenital Heart Disease II 
Tuesday, April 01, 2003, Noon-2:00 p.m. 
McCormick Place, Hall A 
Presentation Hour: 1:OO p.m.-2:OO p.m. 
1192-155 Emergency Hospital Admissions and Three-Year 
Survival of Adults With Congenital Cardiac Disease 
Sohrab Fratz Harald Kaemmerer, Ulnke Bauer, Erwin Oechsltn, Alfred Hager, Silke 
Brodherr-Heberlein, Bernhard Zrenner, John Hess, Deutsches Herzzentrum Munchen. 
TU Miinchen. Munich. Germany, Deutsches Herzzentrum Berlin, Berlin, Germany 
Background: The number of emergency hospital admrssions of adults with congenital 
cardiac disease (ACCD) is increasing. Aim of this study was to determine quantity and 
nature of emergencies leading to an unscheduled hospital admission and mid-term SUP 
viva1 of these patients. Methods: During one year 429 ACCD were admitted 571 times 
into three tertiary care centers. 124 (22 %) admissions of 95 (22 %) patients were acute. 
15 of the 95 patients were seen for the first time. The underlying congenital cardiac 
anOmakes were: Fallot’s tetralogy / pulmonary atresia with ventricular septal defect (~26 
/ 7) univentricular heart after Fontan procedure (~25) atrial septal defect (n=l Et), Eisen- 
manger syndrome (n=12), complete transposition after atrial switch (~1 I), and others 
(n=25). Results: Marn indications for acute hospital admission were cardlo-vascular 
(n=l03; 63%) (arrhythmra, cardiac failure, syncope, pacemaker problems, pericardial 
tamponade, sudden death), Infection (n=8, 6%) (endocardrtis, pacemaker infection, 
pneumonia, cerebral abscess), acute chest pain (~7; 6%). or acute abdomen (~4; 3 
X). 16 patients (17 %) needed urgent cardiovascular or abdominal surgery. Six patients 
(5 % of the admtssions) deceased The survivors were hospitalized for 9+11 days. Dur- 
ing a follow-up of 2.9 * 0.6 years 16 (18 %) of the discharged patients died. Two addi- 
tional patients had a heart / heart-lung transplantation. Conclusions: ACCD can 
